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Abstract
Background: Priority setting in population health is increasingly based on explicitly formulated values. The Patients
Rights Act of the Norwegian tax-based health service guaranties all citizens health care in case of a severe illness, a
proven health benefit, and proportionality between need and treatment. This study compares the values of the
country’s health policy makers with these three official principles.
Methods: In total 34 policy makers participated in a discrete choice experiment, weighting the relative value of six
policy criteria. We used multi-variate logistic regression with selection as dependent valuable to derive odds ratios
for each criterion. Next, we constructed a composite league table - based on the sum score for the probability of
selection - to rank potential interventions in five major disease areas.
Results: The group considered cost effectiveness, large individual benefits and severity of disease as the most
important criteria in decision making. Priority interventions are those related to cardiovascular diseases and
respiratory diseases. Less attractive interventions rank those related to mental health.
Conclusions: Norwegian policy makers’ values are in agreement with principles formulated in national health laws.
Multi-criteria decision approaches may provide a tool to support explicit allocation decisions.
Background
In all health care systems, choices in the allocation of
resources are necessary. Public resources, in both low-
and high-income settings, are insufficient to provide all
possible services to the entire population at all times.
Priority setting in the allocation of health interventions
across ranges of health services or target groups
becomes inevitably and at best should be explicit[1,2].
Scarcity of resources and rational priority setting lead
to identification of national packages of health services
and to explicit reimbursement decisions [3]. In health,
policy makers often may have to confront many groups
with different and conflicting interests [4]. Rational
approaches to guide policy makers become desirable
and allow for navigation of complex social processes
and to handle multifaceted information. The rise of evi-
dence-based health policy has lead to a wealth of infor-
mation on the nature and distribution of the disease
burden and related societal costs as well on the effec-
tiveness and efficiency of health interventions, and on
their budget impact [5]. Existing approaches may con-
centrate on one or two criteria like safety and effective-
ness, or also efficiency [6,7] with real world decision
makers having to handle multidimensional information
[2,8]. So far, priority setting tends to focus primarily on
effectiveness and efficiency and less on equity-related
social values [9].
Norway has adopted a well-developed comprehensive
system in which complex problems and scientific sup-
port mechanisms such as health technology assessment
and value-based priority-setting criteria were brought
together to generate transparent solution [10]. As one of
the richest countries it ranks second following the Uni-
ted States in health care spending and it enjoys one of
the highest population health levels in the world.
(OECD 2011[11]) The key elements of its health policy
include provisions of health services for all based on
needs regardless of personal income, local and regional
accountability, public commitment and political interest
in improving the health system [12]. Its health system is
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universal coverage of primary care under the responsi-
bility of the municipalities and with specialized care
under national governance.
In 2007 a Council for Quality Improvement and Prior-
ity Setting was established “to debate, implement, regu-
late, and supervise” the national health plan under the
Patient Rights Act of 2001. As such, the Norway situa-
tion provides a unique opportunity to compare formal
health goals to actual policy makers preferences in
priority setting.
Our study objective is to assess if policy-makers’
actual value preferences agree with those formulated in
the legal domain through the Patient Rights Act
(PRA). The Act identifies three prioritizing rules:
severity of the condition (those most in need must be
helped first), expected health outcome, and, lastly, pro-
portionality between need and treatment (with cost-
effectiveness analysis providing this information). We
used discrete choice experiments (DCE), a methodol-
ogy that allows simultaneous assessment of multiple
policy preferences in multi-criteria decision analysis
(MCDA) for policy as we reported earlier in other case
studies[9,13-15].
Methods
MCDA consists of four steps: (I) identification of policy
criteria and metrics, (II) identifying series of alternative
package vignettes based on various combinations of pol-
icy criteria, (III) measuring performance of alternatives
by criteria (this is often done through a DCE question-
naire but can also be completed in various other ways),
and (IV) determining the preferred selection through
scoring intervention options against those criteria. The
last step provides a broad classification and ranking of
interventions within a chosen context or specific disease
area (a composite league table). Although the league
table is not an integral part of the MCDA methods but
rather an illustrative application, it is often seen as the
most important contribution of a MCDA.
Discrete choice survey and criteria attributes
A DCE is a stated-preference technique that uses an
attribute-based survey method for measuring prefer-
ences for multiple benefits (utility). The survey elicits
respondents’ preferences based on their stated prefer-
ences in hypothetical and forced choices between two
vignettes or, in our study, two sets of specified policy
criteria. The choice vignettes are drawn, ap r i o r i ,f r o m
all possible choice sets according to statistical design
principles [16]. In stating ap r e f e r e n c ef o ro n eo ft h e
two vignettes, the individual is assumed to make trade-
offs and choose the alternatives that yield the highest
personal preference or benefit or utility [17].
The first step is the identification of context-relevant
criteria and their levels. In general, criteria must be rele-
vant to the stated policy choices and usually include
some combination of equity-related and/or efficiency-
related factors. Here, equity factors may be viewed as
related to the distributional impact and often relate to
w h o mi nam o r ev u l n e r a b l es t a t er e c e i v e st h ee x p e c t e d
health benefits like those with severe illness, of a high or
low age or low income status. Efficiency factors may
refer to achieving the largest impact at the lowest cost,
the total beneficiaries and hence the total population
impact, or the individual benefits. We used an existing
questionnaire, applied in various settings and reported
earlier for other countries, including The Netherlands
[14,15,18]. The criteria (Table 1) are selected to assure
completeness, feasibility, and mutual independence [3,9],
as based in the earlier country experiences and review
[6,7].
The survey questionnaire is detailed in Table 2 with
the varying levels of criteria attributes that are grouped
and assigned into sets of vignettes. Vignettes contain
always the same attributes yet with differing levels
across vignettes. A full factorial list, including all possi-
ble combination of levels and attribute is often impossi-
ble to use, yet not needed. We applied a fractional
factorial design considering a sample selection of the
possible alternatives. A computer-based software pro-
gram was used to create choice sets regarding consid-
eration on the properties of orthogonality, level balance,
and minimum overlap [2]. Our fractional factorial
design in the study includes a sub-set of 32 vignettes,
paired in 16 sets of choices.
The DCE consists of this set of discrete choices. It
measures preferences between intervention options by
counting the extent to which specified objectives are
p r e f e r r e dm o s t[ 2 , 3 ] .W eu s e dc o n d i t i o n a ll o g i s t i c
regression model in STATA
© to analyze all the
response data together. The independent variables (the
defined policy criteria) are either categorical with two or
three levels and the dependent variable is the preferred
choice i.e. the selected vignette. In case of a three levels
attribute, the young age group is used as the reference
category. The weighing results are presented as regres-
sion coefficients. These indicate the size of the effect of
a criterion on the selection probability of an interven-
tion option fulfilling the criterion [16]. Finally, the calcu-
lated sum weight over all criteria for each intervention
option leads to ranking of the options in a composite
league table based on the probability of selection [14].
Data collection
The DCE survey questionnaires were completed by 34
health professionals selected among all the senior mem-
bers of the Norwegian Directorate of Health and senior
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technique. The selection of respondents was based on
the number of years with relevant experience in actual
decision-making, or their familiarity with economic eva-
luation defined as being actively involved in policy
research in this field.
Data analysis
All levels for criteria were qualitative and data are
dichotomous choice (’1’ represents the option being
chosen, ‘0’ where not chosen). The observed sources of
utility can be defined as a linear expression (main-effects
additive probability model assumption) in which each
attribute is weighted by a unique parameter to account
for that attribute’s marginal utility. Regression coeffi-
cients indicate the sign of the effect of a variable on the
probability of selection of an intervention. The absolute
value of the coefficients denote the relative importance
of particular levels of a criterion in comparison to other
levels of all other criteria so that the criterion which has
higher probability will have more possibility to be used
as the important one in selection of the interventions
than others [16,17].
Composite league table
The last phase in MCDA includes the ranking of inter-
ventions of interest in the country where the research is
performed. In an actual priority-setting context, the aim
of the composite league table is to rank-order the inter-
ventions to identify those that should be included or
excluded from a health initiative (low-income countries)
or public reimbursement (high-income settings). We
selected the interventions in the Norway context to pro-
vide a broad presentation of existing and possible inter-
ventions across several disease areas, to demonstrate
how MCDA may support rational decisions [7].
In the five major disease burden groups (WHO, 2011
[19]) we selected 21 interventions. We consulted the
updated National Clinical Guidelines as issued by the
Directorate for Health and other sources to find the
most appropriate context-given interventions addressing
the five disease groups. The 21 interventions addressed
neuropsychiatric conditions, cardio-vascular diseases,
malignant neoplasms, respiratory diseases, and sensory
organ diseases.
We defined a “composite index” (CI) that represents
the relative priority of each intervention as a function of
their characteristics, based o nt h ec r i t e r i aw e i g h t s .T h e
“probability of selection” is estimated for each interven-
tion using the regression model and a rank ordering of
all intervention on the basis of this composite index
results in a composite league table [15].
Our main effect model uses the following specifica-
tion:
Logit(P) = Ln(P/1 − P) = β0 + βiVi + βiVi + ...+ ε (1)
Table 1 Definition of attributes and levels
Attribute Level Definition
Severity of disease Not severe Health expectancy > 2 years without intervention
Severe Health expectancy < 2 years
Number of potential beneficiaries Few < 100 000
Many > 100 000
Age of target group Young age 0-15 years old
Middle-age 15-59 years old
Elderly > 60 years old
Individual health benefits Small < 5 healthy years
Large > 5 healthy years
Willingness to subsidize > 70% of total health expenditure Poverty reduction criteria: subsidize at more or less than 70%.
< 70% of total Health expenditure
Cost-effectiveness Not C-E Cost/DALY > GDP/capita
C-E Cost/DALY< GDP/capita
DALY Disability-adjusted life year
GDP Gross domestic product
Table 2 Pair of competing interventions example in the
DCE questionnaire scenarios.
Choice A B
Severity of disease Severe Not severe
Number of potential beneficiaries Many Few
Age of target group Mid age Old age
Individual health benefits Large Small
Willingness to subsidize > 70% < 70%
Cost-effectiveness Cost effective Not Cost-effective
YOUR CHOICE: tick a box A□ B□
If these were your only options, which would you choose, tick a box: A or B
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the most qualifying intervention based on the joint
inclusion of all relevant criteria and their relative
weights. The b0 is the constant term or intercept, the bi
+nare the indexed coefficients for each the criteria
included in the model, while ε is the unobservable error
term. V has the value of ‘1’ in case the criterion is pre-
sent and ‘0’ when it is absent. The use of this linear
additive utility model is based on the assumption of
mutual independence of the criteria selected.
Computation of the CI involves several steps. The set
of interventions to be prioritized has to be mapped, or
rated, in which way they fit the selected policy criteria.
This fit is indicated by ‘1’ or’0’ to denote levels of the
various criteria, so that the matrix elaborated will indi-
cate, e.g. for cost-effectiveness ‘1’ when the intervention
is CE and ‘0’ if it is not. To illustrate computation, in
Table 3matrix, Atrial fibrillation intervention is rated as
‘0’ for Disease severity criteria that is “no severe”, ‘1’ as
providing significant individual benefit, ‘0’ as not indi-
cated for middle age group, ‘1’ as indicated for high age
group, ‘1’ as the intervention is cost effective... when the
mapping for all criteria is completed, the CI is calcu-
lated, for all interventions, based on the main effect
additive utility model (formula 1), so that Atrial fibrilla-
tion will have as CI: 0*1.08 + 1*1.2638+0* - 0.2004+1*-
1.117+1*1.5045+0*0.3714+1*0.3566 = 2.0079. Asthma no
control will have as CI:1*1.08+1*1.2638-1*0.2004-1*1.117
+1*1.5045+1*0.3714+1*0.3566 = 3.2589. The selection
probability for each interventions is calculated, based on
the general equation: P = EXP (CI)/1+ EXP (CI), the
exponential (EXP) function returns e raised to the nth
power, where e = 2.71828183. The selection probability
for Atrial fibrillation is computed as:
ε2.0079/1 + ε2.0079 or2.712.0079/1 + (2.712.0079) = 7.4476/8.4476 = 0.88.
The research proposal was submitted for ethical
approval to the IRS at the Johns Hopkins Bloomberg
School of Public Health, and has been waived from
requiring any formal ethics approval.
Results
All 34 respondents completed and returned the whole
survey questionnaire. Table 4 shows the results of the
random effects regression model. A positive sign for a
particular level implies a positive impact on the prob-
ability of choosing interventions with that level. As men-
tioned, the absolute values of the regression coefficients
indicate their relative importance in priority setting, in
that respect, cost-effectiveness, individual benefits and
severity of diseases are the most important criteria.
Except for middle age group and the willingness-to-
subsidize criterion, all coefficients showed to be signifi-
cant, and their signs had the expected direction.
Table 3 shows the composite league table results. The
interventions with the highest priority are those addres-
sing cardio-vascular diseases, and next the respiratory
diseases. Those receiving the lowest attractively are
related to mental health.
Discussion
Norwegian policy makers consider cost effectiveness,
individual benefits and severity of disease as important
criteria for priority setting of interventions. The findings
are in line with those that one a priori may expect for a
high-income country with universal coverage where a
willingness to subsidize is less relevant. While using
generic criteria based on other settings, our study con-
firms that the policy makers are consistent and accu-
rately weigh criteria that the Patients Rights Act
prescribes. These are all criteria that patients need to
meet to qualify for needed specialized health care and to
receive the status of ‘entitled patient’.
The results from composite league table can be con-
sidered indicative. It provides an insight in intervention
priorities they are giving or neglecting to address
chronic diseases. Only if cardiovascular diseases and
respiratory diseases are properly addressed, mental
health conditions - such as depression, alcohol disorders
and Alzheimer’s disease - may become attractive. This
may be in conflict with already existing central govern-
ment initiatives that aim to promote control of neurop-
sychiatric conditions, in particular dementia [20].
A limitation in our study is that we did not use well
defined and easily quantifiable criteria based on locally
formulated standards. Recognizing this, we do not avoid
a realistic debate on policy setting in Norway as the cri-
teria selected ex ante are close to the country specific
and country-relevant, as well as the levels of attributes.
Our present full set of criteria chosen describes the
most important generic aspects of a health intervention
as also is found in the two large reviews [6,7]. Also, our
findings are comparable to the preferences of Dutch
policy makers [9]. These two countries seem to favor
efficiency to equity. Additionally, the trends in weights
among Dutch health care groups are similar. Moreover,
interventions will certainly have different perceived or
measured characteristics in other countries. Some of cri-
teria may not be relevant in other countries, yet this is
accounted for by the country-specific weights that pol-
icy-makers in other settings may give to those criteria.
The second constraint i.e. the assumed independence
o ft h ec r i t e r i aa st h e ya r ed e f i n e di nt h eD C Ei si m p o r -
tant. Our approach is not only based on assumed inde-
pendence but also assumed comprehensiveness and
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Page 4 of 7Table 3 Composite League Table (COPD: Chronic obstructive pulmonary disease, K/cancer)
Norway Coefficients 1,08 1,2638 -0,2004 -1,117 1,5045 0,3714 0,3566
Intent
N°
CLINICAL Intervention CRITERIA Comp Select Rank
CONDITION Index Prob
Dis Sev Ind
Ben
Age
Mid
Age
High
CER Tot
benef
WTSub
CVD1 Angina
pectoris
as per Guidelines[apG]
: invest, treat (med-stent surg)
1 1 0 1 1 1 1 3,4593 0,9695
07279
1
CVD2 Atrial
fibrilation
diag, trat anticoag, 0 1 0 1 1 0 1 2,0079 0,8816
24035
13
CVD3 Heart failure Diagn, eval, Med treat 1 1 0 1 1 1 1 3,4593 0,9695
07279
1
CVD4 High
Cholesterol
Preventive screening
/statin treatment
1 0 1 1 1 1 1 1,9951 0,0880
28164
9
14
CVD5 Hypertension Screening, lifestyle
(exerc, diet),ACE treat
1 0 1 1 1 1 1 1,9951 0,0880
28164
9
14
Resp 6 COPD Stade 1-
2
spiro diag, X-ray, gaz
anal, treat adapt, rehab
1 1 1 1 1 1 1 2,1789 0,8983
38657
8
Resp 7 COPD Stade 3-
4
spiro diag, X-ray, gaz
anal, Br dilat, rehab-
O2-Hospi
1 1 1 1 1 1 1 3,2589 0,9629
91608
3
Resp 8 Asthma no
control
diag, stress test.. 1 1 1 1 1 1 1 3,2589 0,9629
91608
3
Resp9 Asthma control treat adjust: inhal
cortic, Beta agonist-
leukot inhibit
1 1 1 1 1 1 1 3,2589 0,9629
91608
3
Resp
10
Tabacco Use Prevention (tax-advert
ban...)
1 0 1 1 1 1 1 1,9951 0,8802
81649
14
Neo 11 Colon/rectum
K
Surgery with/ without
adjuvant treat
1 1 1 1 1 1 1 3,2589 0,9629
91608
3
Neo 12 Breast K Surgery with adjuvant
treat
1 1 1 1 1 1 1 3,2589 0,9629
91608
3
Neo 13 Lung K Surgery with/without
abjuvat treat
1 0 1 1 1 1 1 1,9951 0,8802
81649
14
Neo 14 colon polyps Screening blood
test/colonoscopy
0 1 1 1 1 1 1 2,1789 0,8983
38657
8
Psy 15 Unipolar
depressive
Disorder 1
Med treat outpatient setting/
Gen Pract
0 1 1 1 1 1 1 2,1789 0,8983
38657
8
Psy16 Unipolar
depressive
disorder 2
Med treat/ psycho In
Hospital setting
0 1 1 1 0 1 1 0,6744 0,6624
87692
20
psy17 Alcohol use
disorders
Tx on beverage/legal
age/advert ban
0 0 1 1 1 1 1 0,9151 0,7140
42646
18
psy 18 Alzheimer &
other
dementials
comprehensive in-home
care
0 0 1 1 1 1 1 0,9151 0,7140
42646
18
Psy 19 Alzheimer &
other
dementials
Nursing home/hospital
care
00 1 1 0 1 1 -
0,5894
0,3567
72534
21
Sen
org20
Hearing loss hearing aid 0 1 1 1 1 1 1 2,1789 0,8983
38657
8
Sen
org21
refractive
errors
optical correction 0 1 1 1 1 1 1 2,1789 0,8983
38657
8
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ranking of interventions. This is reflected and has been
tested in the multi-variate regression approach, yet we
cannot not exclude other relevant additional criteria in
real-life settings. In addition, we also need to acknowl-
edge that this type of MCDA provides a way to account
for quantifiable elements of the decision-making pro-
cess, yet other elements like feasibility, transaction costs,
historical or local context, among others, may be diffi-
cult to incorporate into the approach [21]. The latter
are much more related to implementation as to an
informed and explicit priority setting. The present find-
ings are important as they confirm current policies and
do not lead to new insights in the approach of the pol-
icy makers. So, the study and the matching of criteria
provides policymakers with an explicit structure to
assess the extent to which current and future invest-
ments in health interventions in Norway may serve the
country’s societal objectives.
Health decision-makers make difficult decisions on the
use of public funds either in a context-specific priority
setting for reimbursement of interventions, prioritization
between a few options within a constrained budget or,
in a general policy setting where no specific choice has
to be made in a specific resource allocation. At the
moment, Norway is given only an average score in the
OECD’s new health system report [22]. A more forma-
lized and explicit approach that includes methodological
guidance, the use of health information and a transpar-
ent debate on policy formulation may improve the pol-
icy process [23]. Here, to balance policy makers taking
ad-hoc or biased decisions, an approach like MCDA,
while using a composite ranking method may be a valu-
able tool[2]. Ghana is a positive example and has suc-
cessfully used explicit criteria to set its interventions
priorities through the Strategic Plan for health 2007-
2012 while other very divers countries with (almost)
universal access systems continue to develop policy pro-
cesses that includes both equity and efficiency factors
such as in the UK, The Netherlands, Thailand, China,
and others [15].
Conclusions
Although this study used general priority criteria, three
criteria showed to be relevant to Norwegian policy-
makers. The existing implementation of appropriate,
transparent, and fair national guidelines is in line with
the legal, and hence societal values and reflects the
Patients Rights of Act. Priority rankings based on the
same criteria show how MCDA can be used and may
invite a discussion on priority policies across major dis-
ease areas. The findings allow for a prioritization based
on existing features of the modern health care complex-
ities that policy makers are facing.
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